Taiwan - Delayed Quote TWD

Johnson Health Tech .Co., Ltd. (1736.TW)

149.50
-8.50
(-5.38%)
At close: 1:30:20 PM GMT+8
Loading Chart for 1736.TW
  • Previous Close 158.00
  • Open 157.50
  • Bid 149.00 x --
  • Ask 149.50 x --
  • Day's Range 149.50 - 157.50
  • 52 Week Range 84.20 - 226.50
  • Volume 1,091,885
  • Avg. Volume 1,542,693
  • Market Cap (intraday) 45.343B
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) 15.92
  • EPS (TTM) 9.39
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 1.00 (0.63%)
  • Ex-Dividend Date Jul 30, 2024
  • 1y Target Est 268.00

Johnson Health Tech. Co., Ltd. engages in the manufacture and sale of sports and fitness equipment in the Americas, Europe, Asia, and internationally. It offers cardiovascular and weight training equipment, and related electronic components, as well as video transmission and streaming service; researches, develops, manufactures, and trades in massage chairs; and sells food products. The company was incorporated in 1975 and is based in Taichung City, Taiwan.

www.johnsonfitness.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Leisure

Industry

Recent News: 1736.TW

View More

Performance Overview: 1736.TW

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

1736.TW
18.97%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.92%

1-Year Return

1736.TW
63.37%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
0.55%

3-Year Return

1736.TW
192.41%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
34.23%

5-Year Return

1736.TW
142.59%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
100.45%

Compare To: 1736.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1736.TW

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    47.92B

  • Enterprise Value

    63.28B

  • Trailing P/E

    16.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.95

  • Price/Book (mrq)

    3.74

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    10.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.65%

  • Return on Assets (ttm)

    5.75%

  • Return on Equity (ttm)

    25.58%

  • Revenue (ttm)

    50.37B

  • Net Income Avi to Common (ttm)

    2.84B

  • Diluted EPS (ttm)

    9.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.9B

  • Total Debt/Equity (mrq)

    140.51%

  • Levered Free Cash Flow (ttm)

    -1.88B

Research Analysis: 1736.TW

View More

Company Insights: 1736.TW

Research Reports: 1736.TW

View More

People Also Watch